Trifluoperazine Study

Headway welcomes findings of trifluoperazine study Headway has given a cautious welcome to the findings of a new study which found the antipsychotic drug trifluoperazine (TFP) to be successful in reducing swelling following brain injuries. The new treatment, developed by scientists at Aston University in partnership with international academic institutions, works by counteracting the cells’ […]